Stellantis NV shares slipped 1.3% to trade at c4.633, deepening a recent decline as fresh analyst downgrades continued to pressure the stock. Investors are contending with a pair of high-profile rating cuts that have raised doubts about the companys near-term operational recovery.
Analyst actions
On July 9, JPMorgan lowered its rating on the automaker from Overweight to Neutral and reduced its price target from c10.00 to c6.00. The bank said it expects roughly 14 months will be required before savings from lower component purchasing costs are reflected in product launches, effectively deferring any meaningful financial improvement to fiscal 2027 or fiscal 2028 at the earliest.
Earlier in the month, HSBC moved to downgrade Stellantis to Reduce from Hold, cutting its 12-month price target to c4.00 from c5.50. HSBC pointed to a rising U.S. dealer inventory level, which reached 93 days of supply in June 2026 - about 120,000 units higher than a year earlier - and to an elevated number of vehicle recalls in 2026. The bank noted there have been 19 recalls covering roughly 2.5 million units so far this year as central factors behind its more cautious stance.
Market backdrop and investor reaction
The two downgrades have contributed to a broader sense of skepticism among analysts about how quickly Stellantis can execute a turnaround. Italys benchmark index fell 1.3% in the prior session, and Stellantis was the weakest performer on the Milan exchange, trading at five-year lows.
In todays session, U.S. indices were mixed, while geopolitical tensions following U.S. military strikes on Iranian targets have kept energy prices elevated and overall risk appetite subdued. Those conditions tend to be unfavorable for capital-intensive automakers, adding another headwind to investor sentiment toward Stellantis.
Price context and investor expectations
The combination of two bearish analyst moves in quick succession, structural concerns around dealer inventory and product quality, and a soft macro environment left the shares hovering near their 52-week low of c4.618. The stock has lost more than half of its value from its 52-week high of c10.494 as market participants wait for clearer signs that the companys turnaround strategy is translating into measurable financial improvements.
Bottom line
Recent broker downgrades, higher-than-expected U.S. dealer stock levels and numerous recalls, set against a cautious macro backdrop, have collectively driven further weakness in Stellantis shares. Investors remain focused on when cost reductions and sales execution will begin to show in results.